The effects of pentoxifylline infusion on plasma 6‐keto‐prostaglandin F 1α and ex vivo endotoxin‐induced tumour necrosis factor activity in horses

1997 ◽  
Vol 20 (6) ◽  
pp. 487-492 ◽  
Author(s):  
M.H. Barton ◽  
D. Ferguson ◽  
P.J. Davis ◽  
J.N. Moore
2019 ◽  
Vol 13 (7) ◽  
pp. 905-915 ◽  
Author(s):  
Shrinivas Bishu ◽  
Mohammed El Zaatari ◽  
Atsushi Hayashi ◽  
Guoqing Hou ◽  
Nicole Bowers ◽  
...  

Abstract Background and Aims Tumour necrosis factor [TNF]α- and IL-17A-producing T cells are implicated in Crohn’s disease [CD]. Tissue-resident memory T [TRM] cells are tissue-restricted T cells that are regulated by PR zinc finger domain 1 [PRDM1], which has been implicated in pathogenic Th17 cell responses. TRM cells provide host defence but their role in CD is unknown. We thus examined CD4+ TRM cells in CD. Methods Colon samples were prospectively collected at endoscopy or surgery in CD and control subjects. Flow cytometry and ex vivo assays were performed to characterise CD4+ TRM cells. Results CD4+ TRM cells are the most abundant memory T cell population and are the major T cell source of mucosal TNFα in CD. CD4+ TRM cells are expanded in CD and more avidly produce IL-17A and TNFα relative to control cells. There was a unique population of TNFα+IL-17A+ CD4+ TRM cells in CD which are largely absent in controls. PRDM1 was highly expressed by CD4+ TRM cells but not by other effector T cells. Suppression of PRDM1 was associated with impaired induction of IL17A and TNFA by CD4+ TRM cells Conclusions CD4+ TRM cells are expanded in CD and are a major source of TNFα, suggesting that they are important in CD. PRDM1 is expressed by TRM cells and may regulate their function. Collectively, this argues for prospective studies tracking CD4+ TRM cells over the disease course.


Immunology ◽  
1996 ◽  
Vol 87 (2) ◽  
pp. 264-270 ◽  
Author(s):  
S. ENDRES ◽  
R. E. D. WHITAKER ◽  
R. GHORBANI ◽  
S. N. MEYDANI ◽  
C. A. DINARELLO

Sign in / Sign up

Export Citation Format

Share Document